Castleark Management LLC Acadia Pharmaceuticals Inc Transaction History

Castleark Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $3.5 Million - $5.47 Million	-96,045 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $4.59 Million - $6.17 Million	-117,025 Reduced 54.92%	96,045 $4.66 Million
Q1 2020 May 13, 2020	SELL	$31.65 - $46.87 $85,455 - $126,549	-2,700 Reduced 1.25%	213,070 $9 Million
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $858,177 - $1.22 Million	23,700 Added 12.34%	215,770 $9.23 Million
Q3 2019 Nov 15, 2019	BUY	$22.22 - $44.01 $4.27 Million - $8.45 Million	192,070 New	192,070 $6.91 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.